MOLN
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Molecular Partners reported clinical progress in the Phase 2 TACTIC combination trial of MP0317 for cholangiocarcinomaJul 16, 2026
- Molecular Partners and Orano Med dosed the first patients in the Phase 1/2a trial of MP0712Jul 2, 2026
- Molecular Partners published Phase 1 data for MP0317 showing tumor-localized CD40 activation in Nature CancerMay 1, 2026
- Molecular Partners shares positive Phase 1/2a data for MP0533 in AML at EHA 2025Jun 12, 2025